Sponsor a White Coat: Help Prepare the Next Gen of Longhorn Pharmacists

A blonde student wearing a white coat walking in the processional at the ceremony.
June 5, 2023
Your gift of $60 or more will purchase one or more white coats for incoming Texas Pharmacy students. Becoming a sponsor is an exciting and rewarding way for our alumni to make a personal connection with the entering students.

Pharmacy Research Excellence Day 2023

Texas Pharmacy faculty, student and staff standing near poster displays at Pharmacy Research Excellence Day.
April 24, 2023
The Nineteenth Annual Louis C. Littlefield Celebrating Pharmacy Research Excellence Day was held on Tuesday, April 11, 2023, highlighting the impressive accomplishments of Texas Pharmacy researchers at all levels.

Announcing the Winners of the 2022 UT Pharmacy Alumni Awards

Headshots of Dr. Jamie C. Barner, Dr. Emmaneul Enwere and Dr. M. Lynn Crismon.
November 2, 2022
The Texas Pharmacy Alumni Association has selected Emmanuel Enwere, Pharm.D., M.S., CPHIMS, Jamie C. Barner, Ph.D., FAACP, FAPhA and M. Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP as the 2022 Alumni Award recipients. This year's winners will be honored on November 12, 2022 at the Texas Pharmacy Homecoming Tailgate, generously sponsored by H-E-B.

Alumni: Help Prepare the Next Gen—Sponsor a White Coat

Student pharmacist being coated at the 2021 White Coat Ceremony. Text overlap reads "It's more than just a jacket. It's a White Coat."
June 6, 2022
Your gift of $40 or more will purchase one or more white coats for incoming pharmacy students. Becoming a sponsor is an exciting and rewarding way for UT Pharmacy alumni to make a personal connection with the entering students.

Pharmacy Research Excellence Day 2022

People standing in front of a research poster.
April 21, 2022
Back (in-person!) and bigger than ever before, the Eighteenth Annual Louis C. Littlefield Celebrating Pharmacy Research Excellence Day was held on Tuesday, April 12, 2022, fetching a record-breaking number of posters presented and participating researchers.

Announcing the Winners of the 2021 UT Pharmacy Alumni Awards

Three people smiling.
October 26, 2021
The UT College of Pharmacy Alumni Association has selected Benjamin McNabb, Pharm.D., Julie Johnson, Pharm.D. and Jeanne D. Waggener, R.Ph. as the 2021 Alumni Award recipients. 2020 and 2021 Alumni Award winners will be honored on November 13, 2021 at the Pharmacy Homecoming Tailgate, generously sponsored by H-E-B.

PharmE3D Labs Receive R01 Grant for Complex Vaccine Technologies

Three people smiling.
September 24, 2021
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.

Maniruzzaman Lab Earns Grant to Research 3D Printed COVID-19 Treatment

A man holding up a dish in a lab.
May 26, 2021
The UT College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Lab earned a Texas Global Faculty Research Seed Grant for its work on patient-specific treatment of COVID-19.

Suh and PharmE3D Labs Win Fellowships for 3D Bioprinting Research

A woman smiling in front of a sign that says "Pharmacy."
March 18, 2021
Student pharmacist Johana Suh earned an undergraduate fellowship award for research on 3D bioprinted modeling of the neurodegenerative disease NPC-1, or Niemann-Pick disease type C1. Suh is a second-year Doctor of Pharmacy candidate in the UT College of Pharmacy, and serves as an undergraduate researcher in the Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs led by Mo Maniruzzaman, Ph.D.

Inhaled Niclosamide a Potential Effective Antiviral to Treat COVID-19

An infrared image of nasal spray being administered.
September 29, 2020
Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.